Atlas Trials

Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates

Clinical trial NCT02074059 · COMPLETED

Trial details

NCT number
NCT02074059
Sponsor
Windtree Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Respiratory Distress Syndrome
Start date
2014-02-01
Primary completion
2015-10-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.